Concepedia

Chia-Ching Wang

CW

Statistics

Publications

5

Citations

354

H-Index

5

Active since

2016

Affiliations

University of California, San Francisco(Current)

National Cancer Institute

Fred Hutch Cancer Center

NYU Langone Health

National Institutes of Health

Chia-Ching Wang is an author at University of California, San Francisco specializing in immunotherapy, oncology, and antiretroviral therapy.

Publications per year

2016–2024

5

Publications

5

Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A Phase 1 Study

Thomas S. Uldrick, Priscila Gonçalves, Maher Abdul‐Hay et al. · JAMA Oncology · 2019 · 239 citations · Full text

, , +17

Long-term survival in AIDS-related primary central nervous system lymphoma

Neel K. Gupta, Amber Nolan, Antonio Omuro et al. · Neuro-Oncology · 2016 · 68 citations · Full text

, , +16

Cancer Immunotherapy Trials Network 12: Pembrolizumab in HIV-Associated Kaposi Sarcoma

Kathryn Lurain, Ramya Ramaswami, Irene Ekwede et al. · Journal of Clinical Oncology · 2024 · 19 citations · Full text

, , +14

Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma

Chia-Ching Wang, Cassandra Thanh, Erica A. Gibson et al. · Blood Advances · 2018 · 18 citations · Full text

, , +10

Prevalence of Anal Human Papillomavirus Infection and Anal High-Grade Squamous Intraepithelial Lesions Among Men Who Have Sex With Men 50 Years and Older Living With or Without HIV

Alexandra L. Hernandez, Joan F. Hilton, Christopher Scott Weatherly et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2024 · 10 citations · Full text

, , +16

1–5 of 5